Caredx, Inc. (CDNA) fundamentals score
CareDx is a precision medicine company dedicated to improving outcomes for transplant patients and advancing organ health. It delivers solutions designed to empower clinicians and improve patient outcomes.
Services-Medical Laboratories · Healthcare · Listed on NASDAQ
Overall: 8.9 out of 10, Strong long-term fundamentals
- Growth: 9.5/10
- Profitability: 9.1/10
- Financial health: 9.8/10
- Earnings quality: 8.4/10
- Valuation: 6.6/10
Scores are calculated from Caredx, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10
- Globus Medical, Inc. (GMED): 8.4/10